Bufadienolides |
| ||||||
---|---|---|---|---|---|---|---|
Cardenolides |
| ||||||
|
Channel blockers |
| ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Receptor agonists<BR>and antagonists |
| ||||||||||||
Ion transporters |
| ||||||||||||
|
Cardiac stimulants excluding cardiac glycosides (C01C) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adrenergic and dopaminergic agents |
| ||||||||||||||
Phosphodiesterase inhibitors (PDE3I) | |||||||||||||||
Other cardiac stimulants | |||||||||||||||
|
Nitrovasodilators | |
---|---|
Quinolone vasodilators | |
Others | |
|
Sympatholytics (antagonize α-adrenergic vasoconstriction) |
| ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other antagonists |
| ||||||||||||||||||||||||||
|
Nitrovasodilator |
| ||||
---|---|---|---|---|---|
(arteriolar) Potassium channel opener | |||||
(arteriolar) Calcium channel blocker |
| ||||
|
Sulfonamides (and etacrynic acid) |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
Potassium-sparing (at CD) |
| ||||||||
Osmotic diuretics (PT, DL) | |||||||||
Vasopressin receptor inhibitors (DCT and CD) | |||||||||
Other | |||||||||
|
Phenylethanolamine derivatives | |
---|---|
Alpha blockers |
|
Niacin and derivatives | |
Purine derivatives | |
Ergot alkaloids | |
Other peripheral vasodilators |
Antihemorrhoidals for topical use |
| ||||||
---|---|---|---|---|---|---|---|
Antivaricose therapy |
| ||||||
Capillary stabilising agents |
|
β, non-selective | |
---|---|
β1-selective | |
β2-selective | |
α1- + β-selective | |
|
ACE inhibitors ("-pril") | |
---|---|
AIIRAs ("-sartan") | |
Renin inhibitors ("-kiren") | |
Dual ACE/NEP inhibitors | |
Neprilysin inhibitors | |
|
GI tract |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
Liver |
| ||||||||
Blood vessels |
| ||||||||
Combinations | |||||||||
Other | |||||||||
|
0.00 (0 votes)
|